Learn more
Log in
0 followers
Ashvattha Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel hydroxyl dendrimer (HD) therapeutics (HDTs) to treat unmet medical needs in oncology, ophthalmology, and inflammatory diseases.
Industries
Headquarters
Stage
Employees
Links
Jeffrey L. Cleland
7 members
6 members
2 members
Chroma Medicine
1 follower
PepGen
Biogen
96 followers
Vertex Pharmaceuticals
41 followers
Intellia Therapeutics
7 followers
Discover companies